中文 | English
Return
Total: 123 , 1/13
Show Home Prev Next End page: GO
Author:(Cheolwon SUH)

2.Non-gastric Marginal Zone B-cell Lymphoma in Korea: Clinical Features, Treatment, and Prognostic Factors.

Sung Yong OH ; Cheolwon SUH

The Korean Journal of Internal Medicine 2010;25(3):227-236

3.Non-gastric Marginal Zone B-cell Lymphoma in Korea: Clinical Features, Treatment, and Prognostic Factors.

Sung Yong OH ; Cheolwon SUH

The Korean Journal of Internal Medicine 2010;25(3):227-236

4.Serum beta-2 microglobulin in malignant lymphomas: an old but powerful prognostic factor.

Changhoon YOO ; Dok Hyun YOON ; Cheolwon SUH

Blood Research 2014;49(3):148-153

5.Relevance of prognostic index with β2-microglobulin for patients with diffuse large B-cell lymphoma in the rituximab era.

Jihoon KANG ; Shinkyo YOON ; Cheolwon SUH

Blood Research 2017;52(4):276-284

6.Clinical features and survival outcomes of patients with lymphoplasmacytic lymphoma, including non-IgM type, in Korea: a single-center experience.

Jihoon KANG ; Jung Yong HONG ; Cheolwon SUH

Blood Research 2018;53(3):189-197

8.Refractoriness to platelet transfusion after single-donor consecutive platelet transfusions and its relationship to platelet antibodies.

Munho LEE ; Byoung Kook KIM ; Seonyang PARK ; Cheolwon SUH ; Myoung Hee PARK ; Myong Joon CHO

Journal of Korean Medical Science 1988;3(4):143-149

10.Autologous stem cell transplantation for diffuse large B-cell lymphoma with residual extranodal involvement.

Ock Bae KO ; Geundoo JANG ; Shin KIM ; Jooryung HUH ; Cheolwon SUH

The Korean Journal of Internal Medicine 2008;23(4):182-190

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 123 , 1/13 Show Home Prev Next End page: GO